RARRES2 and metabolic syndrome: Chemerin, a recently identified adipokine that regulates adipocyte differentiation, has been positively linked to adiposity, insulin resistance, metabolic syndrome risk factors, and inflammatory markers (Lehrke et al., 2009; Ernst and Sinal, 2010; Sell et al., 2010; Weigert et al., 2010).